In The News

Equities likely to grow, but finding yield remains difficult, by David Gilreath, principal and Chief Investment Officer at Sheaff Brock for CNBC 

While the outlook is still positive for equity stocks, low interest rates have investors searching for yield. Have you considered alternative sources to find higher yields for your portfolio? Dave Gilreath discusses potential investments types that may be able to provide higher yields and gives an outlook on which sectors can provide growth in 2021.  

Ways to Position for the New Infrastructure, by David Gilreath, principal and Chief Investment Officer at Sheaff Brock for FA Financial Advisor 

As the promise of vaccines to overcome coronavirus are fast becoming a reality for 2021, investors may now be able to consider potential for fixing the nation’s deteriorated infrastructure. Dave Gilreath reviews ways advisors might want to prepare for anticipated Congressional attention and federal spending in the coming year.

Straddling the Pandemic and Post-Pandemic Markets, by David Gilreath, principal and Chief Investment Officer at Sheaff Brock for HCP Live^® (formerly MD Magazine/Physicians' Money Digest) 

How do you straddle the transition from a pandemic to a post-pandemic market? Dave Gilreath offers some perspectives on key sectors and industries.

Sheaff Brock announced the firm has been included in the 2020 CNBC Financial Advisor 100, a list ranking the top-rated financial advisory firms of 2020 for their comprehensive planning and financial services that help clients grow and protect their wealth. Read the full announcement here. 

Disclaimer and Methodology

The Start of Something Big When a Lovely Thing Dies?, by David Gilreath, principal and Chief Investment Officer at Sheaff Brock for HCP Live^® (formerly MD Magazine/Physicians' Money Digest) 

Is the run of growth stocks about to end? And, if so, will the next run be in value stocks? Dave Gilreath looks at the past...and toward the future of both.

As Correlations Shift, So Should Asset Allocation Logic, by David Gilreath, principal and Chief Investment Officer at Sheaff Brock for FA Financial Advisor Magazine

With fixed-income performance withering in recent years, advisors are hearing from clients about shrinking yields. But most aren't aware of the trends now erasing deeply-held beliefs about the traditional 60-40 stocks-to-bonds allocation. Dave Gilreath details the correlation changes for Financial Advisor.

This Overlooked Fixed-Income Vehicle Pays High Yields, by David Gilreath, principal at Sheaff Brock, and JR Humphreys, Sheaff Brock Senior Portfolio Manager, for HCPLive.com (formerly MD Magazine)

In a bond market with corporate yields a shadow of their former selves and Treasury yields starting even lower, investors may be well-served to consider preferred shares as an alternative for better income.

All types of investors can improve their financial situation in the current environment, by David Gilreath, principal at Sheaff Brock, for CNBC

Has the coronavirus pandemic caused any financial hardship for your investments recently? Consider these strategies with the potential to improve your financial situation in today’s current environment.

The Investing Herd Data Indicates Potential Opportunity Ahead, by David Gilreath, principal at Sheaff Brock, for Physicians’ Money Digest

How can contrarian buy signals (or, going against the consensus of 'WWTHD') aid investors in the current market? Dave looks at the benefits of 'stepping to a different drummer' when it comes to timing your trades.

Stocks in Bonds' Clothing and the "Yield Rally," by David Gilreath, principal at Sheaff Brock, for Seeking Alpha 

Stocks in bonds’ clothing may be an apt description of how preferred shares tend to work. Preferreds are a strange hybrid of stocks and bonds that, despite the corona-triggered market decline, experienced an increase in dividend yields. Dividend income is the main reason investors should consider them.

Historical Reasons to Believe the Bull Market May Still Have Legs, by David Gilreath, principal at Sheaff Brock, for Seeking Alpha 

Despite fears of a near-term bear market, historical patterns suggest that the S&P may deliver good returns in the coming decade. Not necessarily great, but pretty good. 

CVS and BMY Still Undervalued Despite Strategic Moves, by David Gilreath, principal at Sheaff Brock, for Seeking Alpha 

Despite healthcare stocks having generally good fundamentals in recent years, the market is still underpricing this category due to regulatory fears and the 2020 election healthcare debate. Yet American demand for quality healthcare won’t change, which may provide opportunities for investment growth ahead.